Drug Type Small molecule drug |
Synonyms DSP 3905 |
Target |
Action blockers |
Mechanism Nav1.7 blockers(Sodium channel protein type IX alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuralgia | Phase 1 | United States | 27 Mar 2018 |





